What’s in Ionis Pharmaceuticals Inc (NASDAQ:IONS) After Decline in Shorted Shares?

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Logo

The stock of Ionis Pharmaceuticals Inc (NASDAQ:IONS) registered a decrease of 0.26% in short interest. IONS’s total short interest was 12.89M shares in January as published by FINRA. Its down 0.26% from 12.93 million shares, reported previously. With 1.21 million shares average volume, it will take short sellers 11 days to cover their IONS’s short positions.

The stock increased 0.69% or $0.39 during the last trading session, reaching $57.2. About 1.18M shares traded or 9.73% up from the average. Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) has risen 1.50% since January 8, 2018 and is uptrending. It has outperformed by 1.50% the S&P500.

Ionis Pharmaceuticals, Inc. engages in discovering and developing RNA-targeted therapeutics. The company has market cap of $7.87 billion. The firm markets SPINRAZA, an antisense drug for spinal muscular atrophy in pediatric and adult patients; and Kynamro an oligonucleotide inhibitor for use in patients with homozygous familial hypercholesterolemia to reduce low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein-cholesterol, and as an adjunct to lipid lowering medications and diet. It currently has negative earnings. The Company’s drugs in Phase III development include volanesorsen for the treatment of patients with familial chylomicronemia syndrome and familial partial lipodystrophy; and IONIS-TTRRx, an antisense drug to treat all forms of transthyretin amyloidosis.

More notable recent Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) news were published by: Seekingalpha.com which released: “Ionis: Superb Neurological Pipeline With 5 Additional Pipelines Of Note – Seeking Alpha” on April 23, 2018, also Fool.com with their article: “Don’t Get Too Excited About PTC Therapeutics (Yet) – Motley Fool” published on June 20, 2018, Seekingalpha.com published: “Ionis Shining – Seeking Alpha” on August 13, 2018. More interesting news about Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) were released by: Seekingalpha.com and their article: “Key events next week – healthcare – Seeking Alpha” published on November 30, 2018 as well as Seekingalpha.com‘s news article titled: “FDA Ad Com Thursday for Akcea’s volanesorsen – Seeking Alpha” with publication date: May 08, 2018.

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.